Development of Recombinant Immunotoxins for Hairy Cell Leukemia

por Kreitman, Robert J., Pastan, Ira
Publicado 2020

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues

por Kreitman, Robert J., Arons, Evgeny
Publicado 2022

Immunotoxins: From Design to Clinical Application

por Kreitman, Robert J., Pastan, Ira
Publicado 2021

Immunotoxins Targeting B cell Malignancy—Progress and Problems With Immunogenicity

por Vallera, Daniel A., Kreitman, Robert J.
Publicado 2018

Effect of Antigen Shedding on Targeted Delivery of Immunotoxins in Solid Tumors from a Mathematical Model

por Pak, Youngshang, Pastan, Ira, Kreitman, Robert J., Lee, Byungkook
Publicado 2014

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox

por Robak, Tadeusz, Janus, Agnieszka, Jamroziak, Krzysztof, Tiacci, Enrico, Kreitman, Robert J.
Publicado 2021

Interleukin-4 receptor targeted immunotherapy of human bladder cancer in animal models

por Joshi, Bharat H, Suzuki, Akiko, Leland, Pamela, Lababidi, Samir, Varrichio, Frederick, Kreitman, Robert, Puri, Raj K
Publicado 2014

High prevalence of MAP2K1 mutations in variant and IGHV4-34 expressing hairy-cell leukemia

por Waterfall, Joshua J., Arons, Evgeny, Walker, Robert L., Pineda, Marbin, Roth, Laura, Killian, J. Keith, Abaan, Ogan D., Davis, Sean R., Kreitman, Robert J., Meltzer, Paul S.
Publicado 2013

Cladribine Analogues via O(6)-(Benzotriazolyl) Derivatives of Guanine Nucleosides

por Satishkumar, Sakilam, Vuram, Prasanna K., Relangi, Siva Subrahmanyam, Gurram, Venkateshwarlu, Zhou, Hong, Kreitman, Robert J., Martínez Montemayor, Michelle M., Yang, Lijia, Kaliyaperumal, Muralidharan, Sharma, Somesh, Pottabathini, Narender, Lakshman, Mahesh K.
Publicado 2015

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine

por Atanackovic, Djordje, Kreitman, Robert J, Cohen, Jeffrey, Hardy, Nancy M, Omili, Destiny, Iraguha, Thierry, Burbelo, Peter D, Gebru, Etse, Fan, Xiaoxuan, Baddley, John, Luetkens, Tim, Dahiya, Saurabh, Rapoport, Aaron P
Publicado 2022

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation–positive hairy cell leukemia

por Kreitman, Robert J., Moreau, Philippe, Ravandi, Farhad, Hutchings, Martin, Gazzah, Anas, Michallet, Anne-Sophie, Wainberg, Zev A., Stein, Alexander, Dietrich, Sascha, de Jonge, Maja J. A., Willenbacher, Wolfgang, De Grève, Jacques, Arons, Evgeny, Ilankumaran, Palanichamy, Burgess, Paul, Gasal, Eduard, Subbiah, Vivek
Publicado 2023

Expression of the muscle-associated gene MYF6 in hairy cell leukemia

por Arons, Evgeny, Zhou, Hong, Sokolsky, Mark, Gorelik, Daniel, Potocka, Katherine, Davies, Sarah, Fykes, Erin, Still, Katherine, Edelman, Daniel C., Wang, Yonghong, Meltzer, Paul S., Raffeld, Mark, Wiestner, Adrian, Xi, Liqiang, Wang, Hao-Wei, Stetler-Stevenson, Maryalice, Yuan, Constance, Kreitman, Robert J.
Publicado 2020

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

por Kreitman, Robert J., Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Robak, Tadeusz, le Coutre, Philipp D., Gjertsen, Bjørn T., Troussard, Xavier, Roboz, Gail J., Karlin, Lionel, Gladstone, Douglas E., Kuptsova-Clarkson, Nataliya, Liu, Shiyao, Patel, Priti, Rotolo, Federico, Mitry, Emmanuel, Pastan, Ira, Giles, Francis
Publicado 2021

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

por Chihara, Dai, Arons, Evgeny, Stetler-Stevenson, Maryalice, Yuan, Constance, Wang, Hao-Wei, Zhou, Hong, Raffeld, Mark, Xi, Liqiang, Steinberg, Seth M., Feurtado, Julie, James-Echenique, Lacey, Tai, Chin-Hsien, Patel, Keyur P., Braylan, Raul C., Calvo, Katherine R., Maric, Irina, Dulau-Florea, Alina, Kreitman, Robert J.
Publicado 2021

P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL

por Vit, Filippo, Bittolo, Tamara, Papotti, Robel, Pozzo, Federico, Zucchetto, Antonella, Tissino, Erika, Zaina, Eva, Catarossi, Ilaria, Laureana, Roberta, Olivieri, Jacopo, Bulian, Pietro, Levato, Luciano, D’arena, Giovanni, Armiento, Daniele, Zamò, Alberto, Leich, Ellen, Rosenwald, Andreas, Arons, Evgeny, J. Kreitman, Robert, Gentile, Massimo, Laurenti, Luca, Zaja, Francesco, Tafuri, Agostino, Chiarenza, Annalisa, Ilaria DEL Principe, Maria, Gattei, Valter, Bomben, Riccardo
Publicado 2023

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience

por Chihara, Dai, Gras, Luuk, Zinger, Nienke, Kröger, Nicolaus, Mayer, Jiri, Passweg, Jakob, de Latour, Régis Peffault, Byrne, Jenny, Krüger, William, Bohn, Jan-Paul, Platzbecker, Uwe, Blau, Igor Wolfgang, Bonifazi, Francesca, Helbig, Grzegorz, McDonald, Andrew, Mistrik, Martin, Mohty, Mohamad, Ram, Ron, Sanz, Jaime, Llamas, Carlos Vallejo, Kreitman, Robert J., Hayden, Patrick J., McLornan, Donal, Tournilhac, Olivier, van Gelder, Michel, Yakoub-Agha, Ibrahim
Publicado 2022

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

por Subbiah, Vivek, Kreitman, Robert J., Wainberg, Zev A., Gazzah, Anas, Lassen, Ulrik, Stein, Alexander, Wen, Patrick Y., Dietrich, Sascha, de Jonge, Maja J. A., Blay, Jean-Yves, Italiano, Antoine, Yonemori, Kan, Cho, Daniel C., de Vos, Filip Y. F. L., Moreau, Philippe, Fernandez, Elena Elez, Schellens, Jan H. M., Zielinski, Christoph C., Redhu, Suman, Boran, Aislyn, Passos, Vanessa Q., Ilankumaran, Palanichamy, Bang, Yung-Jue
Publicado 2023

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

por Grever, Michael, Andritsos, Leslie, Banerji, Versha, Barrientos, Jacqueline C., Bhat, Seema, Blachly, James S., Call, Timothy, Cross, Matthew, Dearden, Claire, Demeter, Judit, Dietrich, Sasha, Falini, Brunangelo, Forconi, Francesco, Gladstone, Douglas E., Gozzetti, Alessandro, Iyengar, Sunil, Johnston, James B., Juliusson, Gunnar, Kraut, Eric, Kreitman, Robert J., Lauria, Francesco, Lozanski, Gerard, Parikh, Sameer A., Park, Jae, Polliack, Aaron, Ravandi, Farhad, Robak, Tadeusz, Rogers, Kerry A., Saven, Alan, Seymour, John F., Tadmor, Tamar, Tallman, Martin S., Tam, Constantine S., Tiacci, Enrico, Troussard, Xavier, Zent, Clive, Zenz, Thorsten, Zinzani, Pier Luigi, Wörmann, Bernhard
Publicado 2021

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

por Kreitman, Robert J., Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Karlin, Lionel, Robak, Tadeusz, Gladstone, Douglas E., le Coutre, Philipp, Dietrich, Sascha, Gotic, Mirjana, Larratt, Loree, Offner, Fritz, Schiller, Gary, Swords, Ronan, Bacon, Larry, Bocchia, Monica, Bouabdallah, Krimo, Breems, Dimitri A., Cortelezzi, Agostino, Dinner, Shira, Doubek, Michael, Gjertsen, Bjorn Tore, Gobbi, Marco, Hellmann, Andrzej, Lepretre, Stephane, Maloisel, Frederic, Ravandi, Farhad, Rousselot, Philippe, Rummel, Mathias, Siddiqi, Tanya, Tadmor, Tamar, Troussard, Xavier, Yi, Cecilia Arana, Saglio, Giuseppe, Roboz, Gail J., Balic, Kemal, Standifer, Nathan, He, Peng, Marshall, Shannon, Wilson, Wyndham, Pastan, Ira, Yao, Nai-Shun, Giles, Francis
Publicado 2018

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

por Ravandi, Farhad, Kreitman, Robert J., Tiacci, Enrico, Andritsos, Leslie, Banerji, Versha, Barrientos, Jacqueline C., Bhat, Seema A., Blachly, James S., Broccoli, Alessandro, Call, Timothy, Chihara, Dai, Dearden, Claire, Demeter, Judit, Dietrich, Sasha, Else, Monica, Epperla, Narendranath, Falini, Brunangelo, Forconi, Francesco, Gladstone, Douglas E., Gozzetti, Alessandro, Iyengar, Sunil, Johnston, James B., Jorgensen, Jeffrey, Juliusson, Gunnar, Lauria, Francesco, Lozanski, Gerard, Parikh, Sameer A., Park, Jae H., Polliack, Aaron, Quest, Graeme, Robak, Tadeusz, Rogers, Kerry A., Saven, Alan, Seymour, John F., Tadmor, Tamar, Tallman, Martin S., Tam, Constantine S., Thompson, Philip A., Troussard, Xavier, Zent, Clive S., Zenz, Thorsten, Zinzani, Pier Luigi, Wörmann, Bernhard, Rai, Kanti, Grever, Michael
Publicado 2022